Northwest & Ethical Investments’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.07M | Buy |
52,006
+12,693
| +32% | +$993K | 0.1% | 201 |
|
|
2025
Q1 | $2.85M | Sell |
39,313
-35,995
| -48% | -$2.61M | 0.08% | 222 |
|
|
2024
Q4 | $5.58M | Buy |
+75,308
| New | +$5.58M | 0.15% | 175 |
|
|
2021
Q3 | – | Sell |
-13,354
| Closed | -$1.38M | – | 408 |
|
|
2021
Q2 | $1.38M | Hold |
13,354
| – | – | 0.04% | 274 |
|
|
2021
Q1 | $1.12M | Hold |
13,354
| – | – | 0.04% | 320 |
|
|
2020
Q4 | $1.22M | Hold |
13,354
| – | – | 0.05% | 305 |
|
|
2020
Q3 | $1.07M | Buy |
13,354
+6,112
| +84% | +$488K | 0.05% | 302 |
|
|
2020
Q2 | $500K | Buy |
+7,242
| New | +$500K | 0.02% | 341 |
|
|
2018
Q4 | – | Sell |
-1,875
| Closed | -$109K | – | 377 |
|
|
2018
Q3 | $109K | Sell |
1,875
-1,200
| -39% | -$69.6K | 0.01% | 329 |
|
|
2018
Q2 | $149K | Hold |
3,075
| – | – | 0.01% | 334 |
|
|
2018
Q1 | $143K | Hold |
3,075
| – | – | 0.01% | 335 |
|
|
2017
Q4 | $116K | Buy |
3,075
+900
| +41% | +$33.8K | 0.01% | 335 |
|
|
2017
Q3 | $79.2K | Hold |
2,175
| – | – | ﹤0.01% | 350 |
|
|
2017
Q2 | $85.7K | Hold |
2,175
| – | – | 0.01% | 352 |
|
|
2017
Q1 | $68.2K | Sell |
2,175
-141,600
| -98% | -$4.44M | ﹤0.01% | 367 |
|
|
2016
Q4 | $4.49M | Sell |
143,775
-5,325
| -4% | -$166K | 0.31% | 77 |
|
|
2016
Q3 | $5.99M | Buy |
149,100
+68,700
| +85% | +$2.76M | 0.42% | 54 |
|
|
2016
Q2 | $2.67M | Buy |
+80,400
| New | +$2.67M | 0.2% | 121 |
|